® 5 "

: Montelukast Teva ® 5 Mg. ?  »
|
-

PER OS

Chewable Tablets

Montelukast Teva is indicated in pediatric patients 6 to 14 years of age for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction.Montelukast Teva is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. Montelukast Teva and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. Montelukast Teva is indicated for the relief of symptoms of seasonal allergic rhinitis in pediatric patients 6 to 14 years of age and older.

140 56 31652 01

Teva Pharmaceutical Industries Ltd

.
, .
.
/
Montelukast as sodium 5 MG
Blister aluminium /aluminium 60 x TABLETS 24
Blister aluminium /aluminium 7 x TABLETS 24
Blister aluminium /aluminium 10 x TABLETS 24
Blister aluminium /aluminium 14 x TABLETS 24
Blister aluminium /aluminium 20 x TABLETS 24
Blister aluminium /aluminium 28 x TABLETS 24
Blister aluminium /aluminium 30 x TABLETS 24
Blister aluminium /aluminium 56 x TABLETS 24

*

*

 

.

? !
 »
 
" !
 

? !
 »
169
-